Antithrombotic Therapy for Atrial Fibrillation

2012/02/01 by John J. You, Daniel E. Singer, Patricia A. Howard +12 · 3 citations
Medicine · #Antiplatelet Therapy and Cardiovascular Diseases #Atrial Fibrillation Management and Outcomes #Venous Thromboembolism Diagnosis and Management

paper · pdf · doi:10.1378/chest.11-2304

crossref issued 2012/02/01 · crossref published 2012/02/01 · crossref published-print 2012/02/01 · openalex publication_date 2012/02/01 · crossref created 2012/02/07 · openalex created_date 2016/06/24 · crossref deposited 2025/09/15 · crossref indexed 2026/07/16 · openalex updated_date 2026/08/01

Citations

• Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
• Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
• Lifetime Risk for Development of Atrial Fibrillation

Cited by

• Stroke Prevention in Atrial Fibrillation
• 2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
• The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study
• Atrial fibrillation [wikipedia]